Please login to the form below

Not currently logged in

vaccine sales

This page shows the latest vaccine sales news and features for those working in and with pharma, biotech and healthcare.

Pfizer starts RSV trial ahead of winter season

Pfizer starts RSV trial ahead of winter season

In a recent financial update, GSK stated it expected peak sales for the vaccine of $4bn. ... Janssen also has a phase 3 trial looking at its vaccine candidate, Ad26.RSV.preF.

Latest news

More from news
Approximately 0 fully matching, plus 65 partially matching documents found.

Latest Intelligence

  • The good, the bad and the ugly The good, the bad and the ugly

    This was driven largely by higher-than-expected sales of its pneumonia vaccine, Prevnar, which accounted for more than 11% of its total revenues in the third quarter of 2017. ... Its closest rival, Novartis, also grew impressively - boasting a projected

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...